IDEAYA Biosciences Inc.

16.59
-0.46 (-2.70%)
At close: Mar 31, 2025, 10:33 AM

IDEAYA Biosciences Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -274.48M -112.96M -58.66M -49.76M -34.49M -41.98M -34.35M -11.86M
Depreciation & Amortization 3.83M 4.01M 2.1M 1.73M 1.38M 1.25M 886K 391K
Stock-Based Compensation 34.75M 18.49M 11.63M 8.24M 3.61M 2.17M 950K 136K
Other Working Capital 3.25M -16.04M -44.31M -23.54M 83.77M -89K 1.33M 1.31M
Other Non-Cash Items -23.23M -11.55M -695K 1.83M 562K -467K 4.11M -2.43M
Deferred Income Tax n/a n/a n/a n/a n/a n/a -873K -27K
Change in Working Capital 11.55M -13.21M -41.55M -17.81M 84.41M -284K 1.65M 1.56M
Operating Cash Flow -247.58M -115.22M -87.17M -55.78M 55.46M -39.31M -27.62M -12.22M
Capital Expenditures -3.86M -2.37M -3.44M -2.64M -493K -1.35M -1.71M -1.76M
Acquisitions n/a n/a 33.4M 67.02M -18K -8K n/a n/a
Purchase of Investments -1.19B -595.98M -255.81M -315M -242.31M -88M -133.3M -13.47M
Sales Maturities Of Investments 692.61M 439.89M 225.85M 247.97M 96.56M 91.62M 71.83M 6.3M
Other Investing Acitivies n/a n/a -33.4M -67.02M 18K 8K -61.47M -7.17M
Investing Cash Flow -502.56M -158.46M -33.4M -69.67M -146.24M 2.27M -63.18M -8.93M
Debt Repayment n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 23.32M 52.95M 2.2M 2.2M 1.52M 289K 105.38M 17.49M
Financial Cash Flow 677.55M 362.72M 97.17M 145.45M 128.75M 50.61M 105.38M 17.49M
Net Cash Flow -72.59M 89.04M -23.41M 20.01M 37.97M 13.56M 14.58M -3.66M
Free Cash Flow -251.44M -117.59M -90.62M -58.42M 54.97M -40.67M -29.33M -13.98M